| Biogen and Ionis Pharma shares slide as they end development of ALS treatment | 05/16 14:07 | marketwatch.com |
| Biogen, Ionis to discontinue development of ALS drug | 05/16 07:41 | reuters.com |
| Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis | 05/16 07:30 | prnewswire.com |
| Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis | 05/16 07:30 | globenewswire.com |
| Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector | 05/15 13:15 | zacks.com |
| Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status | 05/14 19:33 | globenewswire.com |
| 3 S&P 500 Stocks to Rival Nvidia's 2023 Performance in the Second Half of 2024 | 05/11 08:00 | investorplace.com |
| The 3 Most Undervalued Pharma Stocks to Buy in May 2024 | 05/09 06:30 | investorplace.com |
| Biogen Reports Progress on Corporate Responsibility Priorities | 05/02 07:30 | globenewswire.com |
| 7 Retirement Stocks to Buy at a 52-Week Low in April | 04/29 10:03 | investorplace.com |